| Lastest Insider Transactions Of Immunovant, Inc. ( IMVT ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2026-01-21 | Sell | 1,977 | 26.03 | 51,461 | 2026-01-23 16:21:29 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2026-01-07 | Sell | 1,203 | 26.53 | 31,914 | 2026-01-09 16:03:09 |
| IMVT | Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | 2025-12-18 | Sell | 10,813 | 26.91 | 290,943 | 2025-12-19 16:05:25 |
| IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Directior 10% Owner | 2025-12-12 | Buy | 16,666,666 | 21.00 | 350,000,000 | 2025-12-12 17:17:21 |
| IMVT | Immunovant, Inc. | Fromkin Andrew J. | Directior | 2025-12-01 | Sell | 22,249 | 23.25 | 517,189 | 2025-12-03 18:14:54 |
| IMVT | Immunovant, Inc. | Hughes Douglas J. | Directior | 2025-12-01 | Sell | 15,000 | 23.24 | 348,665 | 2025-12-03 18:14:22 |
| IMVT | Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | 2025-11-20 | Sell | 12,626 | 23.62 | 298,237 | 2025-11-21 16:24:08 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2025-10-22 | Sell | 2,595 | 19.03 | 49,383 | 2025-10-24 16:38:29 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2025-10-22 | Sell | 2,520 | 19.03 | 47,956 | 2025-10-24 16:36:56 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2025-10-08 | Sell | 1,272 | 16.30 | 20,734 | 2025-10-10 16:03:10 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2025-10-08 | Sell | 1,585 | 16.30 | 25,836 | 2025-10-10 16:01:57 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2025-07-23 | Sell | 2,805 | 18.15 | 50,911 | 2025-07-25 17:11:45 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2025-07-23 | Sell | 2,385 | 18.15 | 43,288 | 2025-07-25 17:10:29 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2025-07-09 | Sell | 1,160 | 17.24 | 19,998 | 2025-07-11 16:15:00 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2025-07-09 | Sell | 1,519 | 17.24 | 26,188 | 2025-07-11 16:13:45 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2025-04-23 | Sell | 1,925 | 14.79 | 28,471 | 2025-04-25 16:17:18 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2025-04-23 | Sell | 2,349 | 14.79 | 34,742 | 2025-04-25 16:15:56 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2025-04-16 | Sell | 2,993 | 14.89 | 44,566 | 2025-04-17 16:08:29 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2025-04-16 | Sell | 8,321 | 14.89 | 123,900 | 2025-04-17 16:07:30 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2025-04-09 | Sell | 28,094 | 12.99 | 364,941 | 2025-04-11 16:05:03 |
| IMVT | Immunovant, Inc. | Fromkin Andrew J. | Directior | 2025-03-07 | Sell | 8,000 | 19.60 | 156,769 | 2025-03-11 16:18:47 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2025-02-19 | Sell | 2,055 | 20.86 | 42,867 | 2025-02-21 16:06:04 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2025-02-19 | Sell | 2,814 | 20.86 | 58,700 | 2025-02-21 16:05:11 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2025-02-19 | Sell | 15,439 | 20.86 | 322,058 | 2025-02-21 16:04:19 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2025-01-22 | Sell | 2,195 | 23.59 | 51,780 | 2025-01-24 16:23:17 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2025-01-22 | Sell | 2,657 | 23.59 | 62,679 | 2025-01-24 16:22:06 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2025-01-15 | Sell | 2,383 | 23.83 | 56,782 | 2025-01-17 16:07:32 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2025-01-15 | Sell | 2,298 | 23.83 | 54,757 | 2025-01-17 16:05:59 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2025-01-15 | Sell | 8,767 | 23.83 | 208,900 | 2025-01-17 16:04:33 |
| IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Directior 10% Owner | 2025-01-13 | Buy | 16,845,010 | 20.00 | 336,900,192 | 2025-01-15 16:36:38 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2025-01-08 | Sell | 4,105 | 24.10 | 98,931 | 2025-01-10 16:12:35 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2025-01-08 | Sell | 5,105 | 24.10 | 123,031 | 2025-01-10 16:11:02 |
| IMVT | Immunovant, Inc. | Pande Atul | Directior | 2024-12-02 | Sell | 7,750 | 28.54 | 221,185 | 2024-12-04 16:22:39 |
| IMVT | Immunovant, Inc. | Hughes Douglas J. | Directior | 2024-12-02 | Sell | 5,425 | 28.54 | 154,830 | 2024-12-04 16:20:16 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-11-20 | Sell | 3,650 | 25.45 | 92,893 | 2024-11-22 16:12:35 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2024-11-20 | Sell | 3,353 | 25.45 | 85,334 | 2024-11-22 16:11:51 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-11-20 | Sell | 4,174 | 25.45 | 106,228 | 2024-11-22 16:09:49 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-11-20 | Sell | 16,692 | 25.45 | 424,811 | 2024-11-22 16:08:23 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-10-23 | Sell | 4,361 | 29.53 | 128,780 | 2024-10-25 16:25:04 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2024-10-23 | Sell | 3,189 | 29.53 | 94,171 | 2024-10-25 16:23:41 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2024-10-23 | Sell | 2,740 | 29.53 | 80,912 | 2024-10-25 16:21:39 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-10-16 | Sell | 9,095 | 28.79 | 261,845 | 2024-10-18 16:31:13 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2024-10-16 | Sell | 3,188 | 28.79 | 91,783 | 2024-10-18 16:30:22 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-10-16 | Sell | 2,860 | 28.79 | 82,339 | 2024-10-18 16:28:55 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-10-16 | Sell | 3,271 | 28.79 | 94,172 | 2024-10-18 16:27:39 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-10-09 | Sell | 5,162 | 29.56 | 152,589 | 2024-10-11 16:04:21 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-10-09 | Sell | 4,460 | 29.56 | 131,838 | 2024-10-11 16:02:43 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-08-21 | Sell | 3,295 | 31.86 | 104,976 | 2024-08-23 16:15:34 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-08-21 | Sell | 3,027 | 31.86 | 96,437 | 2024-08-23 16:10:20 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-08-21 | Sell | 3,027 | 31.86 | 96,437 | 2024-08-23 16:10:20 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2024-07-24 | Sell | 2,813 | 27.76 | 78,089 | 2024-07-26 16:20:52 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2024-07-24 | Sell | 3,456 | 27.76 | 95,939 | 2024-07-26 16:19:37 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-07-24 | Sell | 4,015 | 27.76 | 111,456 | 2024-07-26 16:17:01 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-07-17 | Sell | 2,505 | 29.69 | 74,382 | 2024-07-19 17:42:37 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2024-07-17 | Sell | 3,044 | 29.69 | 90,386 | 2024-07-19 17:41:17 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-07-17 | Sell | 3,123 | 29.69 | 92,733 | 2024-07-19 17:39:46 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-07-17 | Sell | 3,123 | 29.69 | 92,733 | 2024-07-19 17:39:46 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-07-17 | Sell | 2,867 | 29.69 | 85,132 | 2024-07-19 17:38:04 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-07-17 | Sell | 8,685 | 29.69 | 257,888 | 2024-07-19 17:36:22 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-07-09 | Sell | 4,747 | 28.06 | 133,201 | 2024-07-10 17:07:35 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-07-09 | Sell | 1,527 | 28.06 | 42,848 | 2024-07-10 17:06:24 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-07-09 | Sell | 4,619 | 28.06 | 129,609 | 2024-07-10 17:04:37 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-05-22 | Sell | 4,042 | 29.65 | 119,845 | 2024-05-24 16:18:22 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-05-22 | Sell | 16,163 | 29.65 | 479,233 | 2024-05-24 16:15:51 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2024-05-22 | Sell | 3,247 | 29.65 | 96,274 | 2024-05-24 16:13:13 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-05-22 | Sell | 3,242 | 29.65 | 96,125 | 2024-05-24 16:10:35 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2024-04-24 | Sell | 3,261 | 28.90 | 94,243 | 2024-04-26 17:22:51 |
| IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | 2024-04-24 | Sell | 7,239 | 28.90 | 209,207 | 2024-04-26 17:20:44 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-04-24 | Sell | 3,963 | 28.90 | 114,531 | 2024-04-26 17:18:36 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-04-17 | Sell | 9,827 | 29.06 | 285,554 | 2024-04-19 18:06:59 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2024-04-17 | Sell | 8,280 | 29.06 | 240,602 | 2024-04-19 18:05:09 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-04-17 | Sell | 12,253 | 29.06 | 356,049 | 2024-04-19 18:01:06 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-04-17 | Sell | 10,115 | 29.06 | 293,923 | 2024-04-19 17:59:18 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-04-17 | Sell | 34,079 | 29.06 | 990,269 | 2024-04-19 17:57:13 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-04-09 | Sell | 3,689 | 31.18 | 115,023 | 2024-04-10 16:18:28 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-04-09 | Sell | 1,053 | 31.18 | 32,833 | 2024-04-10 16:16:24 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-04-09 | Sell | 4,807 | 31.18 | 149,882 | 2024-04-10 16:14:09 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-02-22 | Sell | 2,930 | 36.15 | 105,920 | 2024-02-23 16:21:17 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-02-22 | Sell | 2,134 | 36.15 | 77,144 | 2024-02-23 16:18:52 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2024-02-22 | Sell | 2,221 | 36.15 | 80,289 | 2024-02-23 16:16:42 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-02-22 | Sell | 2,146 | 36.15 | 77,578 | 2024-02-23 16:14:57 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-02-22 | Sell | 13,454 | 36.15 | 486,362 | 2024-02-23 16:11:14 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2024-01-26 | Sell | 3,027 | 37.92 | 114,778 | 2024-01-29 16:12:54 |
| IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | 2024-01-26 | Sell | 10,101 | 37.92 | 383,012 | 2024-01-29 16:11:23 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2024-01-18 | Sell | 424 | 41.03 | 17,397 | 2024-01-19 16:04:48 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2024-01-11 | Sell | 3,515 | 41.83 | 147,023 | 2024-01-12 16:34:10 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2024-01-05 | Sell | 1,297 | 38.59 | 50,051 | 2024-01-09 16:20:16 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2024-01-05 | Sell | 3,824 | 38.59 | 147,568 | 2024-01-09 16:18:35 |
| IMVT | Immunovant, Inc. | Fromkin Andrew J. | Directior | 2023-12-01 | Sell | 12,350 | 39.73 | 490,697 | 2023-12-05 16:30:51 |
| IMVT | Immunovant, Inc. | Pande Atul | Directior | 2023-12-01 | Sell | 12,350 | 39.73 | 490,668 | 2023-12-05 16:28:23 |
| IMVT | Immunovant, Inc. | MIGAUSKY GEORGE V | Directior | 2023-12-01 | Sell | 12,700 | 39.73 | 504,567 | 2023-12-05 16:25:33 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-11-22 | Sell | 16,217 | 32.78 | 531,581 | 2023-11-24 14:55:26 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2023-11-22 | Sell | 4,055 | 32.78 | 132,920 | 2023-11-24 14:51:58 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2023-11-22 | Sell | 3,265 | 32.78 | 107,024 | 2023-11-24 14:47:51 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2023-11-22 | Sell | 3,265 | 32.78 | 107,024 | 2023-11-24 14:45:07 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2023-11-22 | Sell | 3,252 | 32.78 | 106,598 | 2023-11-24 14:41:27 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2023-10-25 | Sell | 4,107 | 34.66 | 142,349 | 2023-10-27 16:04:03 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2023-10-19 | Sell | 530 | 36.80 | 19,504 | 2023-10-20 16:06:46 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2023-10-10 | Sell | 4,557 | 36.92 | 168,244 | 2023-10-11 16:11:11 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2023-10-05 | Sell | 1,735 | 36.24 | 62,885 | 2023-10-06 17:15:11 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-10-05 | Sell | 5,239 | 36.24 | 189,887 | 2023-10-06 17:10:08 |
| IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Directior 10% Owner | 2023-10-02 | Buy | 1,526,316 | 38.00 | 58,000,008 | 2023-10-04 17:15:20 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-08-30 | Sell | 56,774 | 22.02 | 1,250,338 | 2023-09-01 16:08:12 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2023-08-24 | Sell | 12,286 | 20.30 | 249,406 | 2023-08-25 17:05:29 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2023-08-24 | Sell | 14,386 | 20.30 | 292,036 | 2023-08-25 17:03:35 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2023-08-24 | Sell | 12,333 | 20.30 | 250,360 | 2023-08-25 17:00:47 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2023-08-24 | Sell | 12,333 | 20.30 | 250,360 | 2023-08-25 16:57:56 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-08-14 | Sell | 103,058 | 21.42 | 2,207,178 | 2023-08-16 16:11:12 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-08-07 | Sell | 101,339 | 21.73 | 2,202,097 | 2023-08-08 16:44:48 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2023-07-26 | Sell | 3,917 | 21.63 | 84,725 | 2023-07-27 16:33:09 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2023-07-19 | Sell | 426 | 24.94 | 10,624 | 2023-07-20 16:37:55 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2023-07-19 | Sell | 2,725 | 24.94 | 67,962 | 2023-07-20 16:35:53 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-07-12 | Sell | 3,233 | 19.73 | 63,787 | 2023-07-13 17:11:50 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2023-07-12 | Sell | 1,470 | 19.73 | 29,003 | 2023-07-13 17:10:33 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2023-04-25 | Sell | 509 | 16.29 | 8,292 | 2023-04-26 16:12:40 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2023-04-25 | Sell | 2,633 | 16.29 | 42,892 | 2023-04-26 16:08:26 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2023-04-18 | Sell | 3,423 | 15.27 | 52,269 | 2023-04-19 16:15:12 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Development Officer | 2023-04-18 | Sell | 1,544 | 15.27 | 23,577 | 2023-04-19 16:12:32 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-04-18 | Sell | 3,395 | 15.27 | 51,842 | 2023-04-19 16:09:15 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2023-02-02 | Sell | 537 | 18.24 | 9,795 | 2023-02-03 07:24:19 |
| IMVT | Immunovant, Inc. | Levine Mark S. | Chief Legal Officer | 2023-01-26 | Sell | 10,156 | 18.51 | 187,988 | 2023-01-27 07:20:19 |
| IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Officer | 2023-01-11 | Sell | 4,021 | 16.80 | 67,553 | 2023-01-13 08:21:55 |
| IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Dev. & Tech. Officer | 2023-01-11 | Sell | 60,490 | 16.79 | 1,015,596 | 2023-01-13 08:19:21 |
| IMVT | Immunovant, Inc. | Barnett Eva Renee | Chief Financial Officer | 2023-01-11 | Sell | 4,510 | 16.75 | 75,525 | 2023-01-13 08:16:46 |
| IMVT | Immunovant, Inc. | Macias William L. | Chief Medical Officer | 2023-01-11 | Sell | 44,568 | 16.75 | 746,317 | 2023-01-13 08:13:29 |
